Devices and Diagnostics
Medtech companies in ophthalmology have made some significant strides in recent months. Second Sight and Glaukos, of course, staged IPOs in their pursuit of revolutionary…
Read MoreUPDATE 4/19/16: Avedro Finally Secures FDA Approval Read Full Story Click Here In late February, a joint panel of the Food and Drug Administration voted…
Read MoreChicago—The 6th Annual Ophthalmology Innovation Summit (OIS), held here prior to the annual American Academy of Ophthalmology (AAO) featured a plethora of intriguing early- to…
Read MoreChicago— Jeff George, Global Head of Alcon Inc., introduced himself to the Ophthalmology Innovation Summit community with a far-ranging keynote address, “Accelerating Innovation in Ophthalmology.”…
Read MoreBuilding a successful biotech or biopharma company typically turns on a sentinel event — the pivot, as William J. Link, PhD, Managing Director of Versant…
Read MoreThe rush of innovation in ophthalmology – both in drugs and devices – is driving the Food and Drug Administration to adopt guidelines and standards…
Read MoreCorneal collagen cross-linking has been a vexing specialty for US-based companies trying to guide a product through a cautious FDA. But Massachusetts-based Avedro Inc., continues…
Read MoreWaveTec Vision Systems’ CEO, Tom Frinzi, delivered a bottom-line presentation at the Ophthalmology Innovation Summit @ASCRS in Boston. His six-minute presentation concentrated on the economic…
Read MoreBOSTON — The Third Annual Ophthalmology Innovation Summit (OIS@ASCRS) took place on April 24, just prior to the 2014 annual meeting of the American Society…
Read MoreThe March 14th meeting of the FDA’s Ophthalmic Devices Panel Advisory Committee, which was convened by the FDA to consider the pre-market application (PMA) for…
Read MoreMore than 800 attendees participated in the fifth annual Ophthalmology Innovation Summit, held November 14, 2013, just prior to the annual meeting of the American…
Read MoreOphthalmology is a growing, but challenging, market. Innovation is abounding in its research stages and some people in the know foresee more positive development in…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")